thoughts on AMT-130 & HD interventions broadly
SKY-515 came out with 15-month interim data recently. What was said in the press release was unsurprising in light of the 12-month data shared.
100 Views
𝛼SK or SearchENTITY
uniQure NV (QURE US)
uniQure NV (QURE US)
16
Analysis
Health Care • Netherlands
uniQure N.V. delivers gene therapy with single treatments for curative results. The Company develops a modular platform to bring new disease modifying therapies to patients with severe genetic diseases, as well as offers ongoing clinical programs in hemophilia B and pre-clinical proof-of-concept in Huntington's disease.
more
x